MSOR06 Presentation Time: 10:15 AM: The 3-Year Outcomes of 3D High-Dose-Rate Brachytherapy in Combination with Regional Metastatic Lymph Nodes Intensity-Modulated Radiotherapy in Peripheral Locally Advanced Non-Small Cell Lung Cancer: A Phase I/II Clinical Trial

Li Xiang,Hong-Xia Li,Hao-Wen Pang,Sheng Lin,Pei-Rong Ren,Jing-Bo Wu

doi:10.1016/j.brachy.2021.06.051

MSOR06 Presentation Time: 10:15 AM: The 3-Year Outcomes of 3D High-Dose-Rate Brachytherapy in Combination with Regional Metastatic Lymph Nodes Intensity-Modulated Radiotherapy in Peripheral Locally Advanced Non-Small Cell Lung Cancer: A Phase I/II Clinical Trial

Li Xiang, Hong-Xia Li + Show 4 more

https://doi.org/10.1016/j.brachy.2021.06.051

Copy DOI

Journal: Brachytherapy

Publication Date: May 1, 2021

Affiliation: Affiliated Hospital of Southwest Medical University

#Locally Advanced Non-small Cell Lung Cancer #Advanced Non-Small Cell Lung Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Purpose: To determine the safety, late toxicities, and locoregional control of three-dimensional(3D) high-dose-rate(HDR) brachytherapy in combination with regional metastatic lymph nodes intensity-modulated radiotherapy(IMRT) in patients with peripheral locally advanced non-small cell lung cancer(LA-NSCLC).

Full Text